AIRNA
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD327—491m (Dealroom.co estimates Jul 2024.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | $30.0m | Early VC | |
* | $60.0m | Series A | |
Total Funding | CAD123m |